Rokana Taftaf

1.3k total citations
11 papers, 326 citations indexed

About

Rokana Taftaf is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Rokana Taftaf has authored 11 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Cancer Research and 2 papers in Genetics. Recurrent topics in Rokana Taftaf's work include Cancer Cells and Metastasis (5 papers), Cancer Genomics and Diagnostics (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Rokana Taftaf is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Cancer Genomics and Diagnostics (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Rokana Taftaf collaborates with scholars based in United States, Syria and Denmark. Rokana Taftaf's co-authors include Huiping Liu, Emma J. Schuster, Isabel Romero‐Calvo, Carolina Reduzzi, Nurmaa K. Dashzeveg, Xia Liu, Valery Adorno-Cruz, Mohammad Arabi, Maria Diab and Andrew D. Hoffmann and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Rokana Taftaf

10 papers receiving 324 citations

Peers

Rokana Taftaf

ONCOL

MB

CR

BE

PRM

Dan He China

Samuel H. Lai United States

Xiaohong Ma China

Haruko Kunitomi Japan

Elisabeth Breit Germany

Pauline A. Whitehouse United Kingdom

Feiteng Lu China

Qu Deng United States

Grete Hasvold Norway

Erica B. Friedman United States

Dan He China

Rokana Taftaf

178 ×1.1

ONCOL

226 ×1.7

MB

62 ×0.5

CR

26 ×0.5

BE

62 ×1.4

PRM

Citations per year, relative to Rokana Taftaf Rokana Taftaf (= 1×) peers Dan He

Countries citing papers authored by Rokana Taftaf

Since Specialization

Citations

This map shows the geographic impact of Rokana Taftaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rokana Taftaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rokana Taftaf more than expected).

Fields of papers citing papers by Rokana Taftaf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rokana Taftaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rokana Taftaf. The network helps show where Rokana Taftaf may publish in the future.

Co-authorship network of co-authors of Rokana Taftaf

This figure shows the co-authorship network connecting the top 25 collaborators of Rokana Taftaf. A scholar is included among the top collaborators of Rokana Taftaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rokana Taftaf. Rokana Taftaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Li, Dong, Younhee Park, Rokana Taftaf, et al.. (2023). ICAM-1-suPAR-CD11b Axis Is a Novel Therapeutic Target for Metastatic Triple-Negative Breast Cancer. Cancers. 15(10). 2734–2734. 8 indexed citations

2.

Taftaf, Rokana, et al.. (2023). Aldosterone- and Cortisol Co-secreting Adrenal Cortical Neoplasm With Lipomatous and Myelolipomatous Metaplasia  . JCEM Case Reports. 1(2). luad012–luad012.

3.

Liu, Xia, Valery Adorno-Cruz, Ya-Fang Chang, et al.. (2021). EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer. Theranostics. 11(13). 6632–6643. 52 indexed citations

4.

Schuster, Emma J., et al.. (2021). Better together: circulating tumor cell clustering in metastatic cancer. Trends in cancer. 7(11). 1020–1032. 157 indexed citations

5.

Adorno-Cruz, Valery, Andrew D. Hoffmann, Xia Liu, et al.. (2020). ITGA2 promotes expression of ACLY and CCND1 in enhancing breast cancer stemness and metastasis. Genes & Diseases. 8(4). 493–508. 46 indexed citations

6.

Dashzeveg, Nurmaa K., Rokana Taftaf, Erika K. Ramos, et al.. (2017). New Advances and Challenges of Targeting Cancer Stem Cells. Cancer Research. 77(19). 5222–5227. 16 indexed citations

7.

Tabarroki, Ali, Rokana Taftaf, Valeria Visconte, et al.. (2014). Rates of Infection in Myelofibrosis Patients Treated with Ruxolitinib. Blood. 124(21). 1835–1835. 2 indexed citations

8.

Taftaf, Rokana, et al.. (2014). Benign Metastasizing Leiomyoma: A Rare Type of Lung Metastases—Two Case Reports and Review of the Literature. Case Reports in Oncological Medicine. 2014. 1–4. 20 indexed citations

9.

Tabarroki, Ali, Valeria Visconte, Rokana Taftaf, et al.. (2014). Burden of Disease and Clinical Responses in Low and Intermediate-1 Risk Myelofibrosis Patients Treated with Ruxolitinib. Blood. 124(21). 1834–1834. 1 indexed citations

10.

Diab, Maria, Rokana Taftaf, & Mohammad Arabi. (2011). Research productivity in Syria: Quantitative and qualitative analysis of current status. SHILAP Revista de lepidopterología. 1(1). 4–7. 23 indexed citations

11.

Firwana, Belal, Nazir Ibrahim, Rokana Taftaf, et al.. (2011). Medical therapeutic agents for Wilson's disease. Cochrane Database of Systematic Reviews. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact